Latest Listicles

This listicle explores how cancer hijacks key cell signaling pathways such as PI3K, MAPK and Notch to drive tumor growth, evade the immune system and resist treatment.

This article explores five key advances driving pharmacogenomics, including long-read sequencing, AI, real-world data integration, polygenic risk scores and multiomics, all aiming to improve personalized medicine and drug response predictions

Explore how AI and automation are shaping the future of biopharmaceutical manufacturing.

Scientific researchers are discovering all kinds of applications for artificial intelligence and machine learning (AI/ML). This listicle will explore how AI/ML is being used in scientific research to accelerate discoveries and improve efficiency.

Some genetic diseases, like sickle cell anemia, are hereditary and present at birth. Others can be caused by spontaneous mutations, either arising from errors in DNA replication or exposure to environmental factors.

This listicle explores four ways that AI and ML are accelerating the biopharmaceutical lifecycle and two big ways that companies are starting to think about their data differently.

By taking a multidisciplinary approach that integrates engineering, electronics and nanotechnology with state-of-the-art chemistry and molecular diagnostics tools, we are entering a new phase of personalized medicine. Download this listicle to learn more about the four top trends in personalized medicine.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.

Download this listicle to learn about developments in immunotherapy, AI/machine learning and cancer vaccines.

Deciding to implement ontologies into your data management practices can be daunting and a difficult sell to business stakeholders. This article outlines the challenges and offers 10 guidelines for kickstarting your ontologies journey.